NASDAQ : HEAL

Global X HealthTech ETF

$28.93 USD

$0.02 (0.07%)

Volume
809
Average Volume
8.19K
Market Capitalization
$31.66M
P/E Ratio
Dividend Yield
%
Price Target
Year High
$33.59
Year Low
$23.00
Day High
Day Low
Payout Ratio
Current Ratio
Company Overview

NASDAQ

Alexander Dobranowski

Asset Management

Financial Services

HEAL

N/A

US

USD

1-888-493-8631

37954Y137

N/A

Liquidity Metrics

Sales & Valuation

-$

Profitability

-$

%

%

%

%

P/E Metrics

Analyst Price Target & Rating

N/A

0/5

0 Analysts

%

Financial Health Scores

No financial score data available.

Key Metrics (TTM)

No key metrics data available.

Company Executives

No executive data available.

Poll Results

No votes yet today — be the first to share your view!

About Global X HealthTech ETF (NASDAQ:HEAL) Stock

HEAL aims to focus on tech-driven innovation in the healthcare sector. As such, the fund seeks to provide exposure to firms looking to shape the future of healthcare by improving patient outcomes and driving medical breakthroughs. Companies around the world, including ADRS, that engage in healthcare analytics and software, smart medical devices, AI-enabled drug discovery, and tech-enabled consumer healthcare. The underlying index screens for companies that are found in FactSet industries identified by the index administrator as relating to healthcare technology and derive at least 50% of their revenue from one or more of the subthemes. Prior to April 1, 2025, the fund tracked a narrower index targeting telemedicine and digital health, the Solactive Telemedicine & Digital Health Index. The ... fund name was Global X Telemedicine & Digital Health ETF and traded using the ticker EDOC.

Restart Life Sciences Announces Production Launch of New Holy Crap Protein Line

2026-08-11 06:00:00

Vancouver, British Columbia--(Newsfile Corp. - August 11, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that its wholly owned subsidiary, Holy Crap Foods Inc. ("Holy Crap"), has officially commenced commercial production of its highly anticipated new protein-focused product line. This marks a significant milestone in the Company's product development roadmap and underscores its core focus on revenue generation, scalable innovation, and expanding its "better-for-you" functional food portfolio.

Restart Life Sciences Details U.S. E-Commerce Launch, AI Platform, and Three-Phase Expansion Strategy for Holy Crap Foods

2026-07-21 06:00:00

Vancouver, British Columbia--(Newsfile Corp. - July 21, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is providing a corporate update regarding its upcoming expansion into the United States, the launch of an updated AI-driven e-commerce platform, and pipeline developments for its wholly owned subsidiary, Holy Crap Foods Inc. ("Holy Crap"). The Company remains focused on scaling operations, driving revenue generation, and expanding its distribution reach.

Restart Life Sciences Leverages University of Manitoba RCFTR Collaboration for Pre-Production Transition of New Protein Frameworks

2026-07-14 06:00:00

Vancouver, British Columbia--(Newsfile Corp. - July 14, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to provide a strategic operational update regarding its collaboration with the Richardson Centre for Food Technology and Research (RCFTR) at the University of Manitoba. Following the recent unveiling of its newly formulated product roadmap, targeted to capitalize on emerging consumer shopping patterns, the Company has successfully integrated the results from its collaboration with the RCFTR into its upcoming formulations.

Restart Life Sciences Details Next-Generation Product Pipeline and Segment Expansion for Holy Crap

2026-07-08 06:00:00

Vancouver, British Columbia--(Newsfile Corp. - July 8, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to provide an update on its forward-looking product development and segment expansion roadmap for its wholly owned subsidiary, Holy Crap Foods Inc. Following the Company's recent disclosure of its preliminary June 2026 financial growth highlights, management is working to build upon this operational trajectory by systematically diversifying the Holy Crap brand into specialized consumer demographics. Following the successful completion of its market research and conceptual design phases, the Company has advanced into formulation testing for a new product line targeting the premium youth breakfast sector.

Restart Life Sciences Reports Record-Breaking June Revenue for Holy Crap Foods as Amazon Canada Sales Surge YoY

2026-07-02 06:00:00

Vancouver, British Columbia--(Newsfile Corp. - July 2, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to report its preliminary, unaudited financial results for the month of June 2026 regarding its wholly owned subsidiary, Holy Crap Foods Inc., alongside an update on internal operational infrastructure and market expansion initiatives. Following the acquisition of Holy Crap Foods Inc. on February 27, 2026, the Company has focused on integrating operations, improving channel efficiencies, and expanding distribution networks.

Restart Life Advances AI-Driven E-Commerce Strategy to Scale Online Sales Growth for Holy Crap Foods

2026-06-18 06:00:00

Vancouver, British Columbia--(Newsfile Corp. - June 18, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that its wholly owned subsidiary, Holy Crap Foods Inc., is preparing to begin harnessing predictive AI to further its e-commerce consumer and wholesale sales platform. The initiative is engineered to leverage readily available predictive consumer behavior models to optimize, monetize, and scale the brand's direct-to-consumer and business-to-business reach.

Restart Life Subsidiary Holy Crap Foods Marks New International Expansion Milestone with Bahamas On-Demand App Launch

2026-06-10 08:00:00

Vancouver, British Columbia--(Newsfile Corp. - June 10, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that its wholly owned subsidiary, Holy Crap Foods Inc., has officially launched a targeted market test and comprehensive product trial across the Commonwealth of The Bahamas. The pilot program is being executed in direct partnership with a premier mobile-first delivery application, digital logistics, and marketplace platform based in the region.

Restart Life Sciences Appoints Inez Ho as Chief Financial Officer

2026-06-03 06:00:00

Vancouver, British Columbia--(Newsfile Corp. - June 3, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce the appointment of Inez Ho as Chief Financial Officer (CFO) of the Company, effective immediately. Ms. Ho brings over 12 years of robust finance and accounting experience to Restart Life, with a strong track record of supporting publicly listed companies across diverse industries.

Frequently Asked Questions

What is the current Global X HealthTech ETF (HEAL) stock price?

Global X HealthTech ETF(NASDAQ:HEAL) stock price is $28.93 in the last trading session. During the trading session, HEAL stock reached the peak price of $33.59 while $23 was the lowest point it dropped to. The percentage change in HEAL stock occurred in the recent session was 0.07% while the dollar amount for the price change in HEAL stock was $0.02.

HEAL's industry and sector of operation?

The NASDAQ listed HEAL is part of Asset Management industry that operates in the broader Financial Services sector.

Who are the executives of HEAL?

|
|
|
|
|

How many employees does HEAL have?

Number of HEAL employees currently stands at None. HEAL operates from 605 Third Avenue, 43rd Floor, New York, NY 10158, US.

Link for HEAL official website?

Official Website of HEAL is: https://www.healwell.ai

How do I contact HEAL?

HEAL could be contacted at phone #1-888-493-8631 and can also be accessed through its website. HEAL operates from 605 Third Avenue, 43rd Floor, New York, NY 10158, US.

How many shares of HEAL are traded daily?

The average number of HEAL shares traded daily for last 3 months was 8.19K.

What is the market cap of HEAL currently?

The market value of HEAL currently stands at $31.66M with its latest stock price at $28.93